IMPROVING STROKE TREATMENT PRACTICES BASED ON HOSPITAL REGISTRY DATA IN ANDIJAN CITY
DOI:
https://doi.org/10.55640/Keywords:
stroke; ischemic stroke; hemorrhagic stroke; hospital data; treatment; rehabilitation; Andijan; Uzbekistan; risk factorsAbstract
Stroke is a serious health problem that causes disability and death. This study looked at stroke patients in Andijan city using hospital registry data from 2020 to 2024. The goal was to understand how patients are treated and how treatment could be improved.Out of 1,312 stroke cases, 71% were ischemic strokes and 29% were hemorrhagic strokes. The average age of patients was 63 years, and 55% were men. The most common health problems were high blood pressure (80%), heart disease (43%), and diabetes (27%). Hemorrhagic stroke patients had more severe symptoms, stayed longer in the hospital, and had higher death rates (29%) compared to ischemic stroke patients (9%). Older age, low consciousness level, and diabetes were linked to higher risk of death.
The study shows that stroke mostly affects older adults with other health problems. Improving treatment with specialized stroke units, faster therapy, and better rehabilitation can help reduce death and improve recovery.
Downloads
References
1.Feigin, V. L., Norrving, B., & Mensah, G. A. (2021). Global Burden of Stroke. Circulation Research, 128(7), 908–922. https://doi.org/10.1161/CIRCRESAHA.120.316059
2.Johnson, C. O., Nguyen, M., Roth, G. A., et al. (2019). Global, regional, and national burden of stroke, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology, 18(5), 439–458. https://doi.org/10.1016/S1474-4422(19)30034-1
3.O’Donnell, M. J., Chin, S. L., Rangarajan, S., et al. (2016). Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): A case-control study. The Lancet, 388(10046), 761–775. https://doi.org/10.1016/S0140-6736(16)30506-2
4.Benjamin, E. J., Muntner, P., Alonso, A., et al. (2019). Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association. Circulation, 139(10), e56–e528. https://doi.org/10.1161/CIR.0000000000000659
5.Sacco, R. L., Kasner, S. E., Broderick, J. P., et al. (2013). An Updated Definition of Stroke for the 21st Century. Stroke, 44(7), 2064–2089. https://doi.org/10.1161/STR.0b013e318296aeca
6.Mendis, S., Davis, S., & Norrving, B. (2015). Organizational Update: The World Health Organization Global Status Report on Noncommunicable Diseases 2014; One More Landmark Step in the Combat Against Stroke and Vascular Disease. Stroke, 46(5), e121–e122. https://doi.org/10.1161/STROKEAHA.115.008097
7.Khan, M. A. B., Hashim, M. J., Mustafa, H., et al. (2020). Global Epidemiology of Ischemic and Hemorrhagic Stroke: A Systematic Review and Meta-Analysis. Neuroepidemiology, 54(3), 171–179. https://doi.org/10.1159/00050639
8.Boehme, A. K., Esenwa, C., & Elkind, M. S. V. (2017). Stroke Risk Factors, Genetics, and Prevention. Circulation Research, 120(3), 472–495. https://doi.org/10.1161/CIRCRESAHA.116.308398
9.Wafa, H. A., Wolfe, C. D. A., Emmett, E., Roth, G. A., Johnson, C. O., & Wang, Y. (2020). Burden of Stroke in Europe: Thirty-Year Projections of Incidence, Prevalence, Deaths, and Disability-Adjusted Life Years. Stroke, 51(8), 2418–2427. https://doi.org/10.1161/STROKEAHA.120.029606
10.Yusupov, A., & Mamatqulov, A. (2023). Epidemiological analysis of stroke in Andijan region based on hospital registry data. Journal of Neurology and Clinical Research, 12(2), 87–93
11.World Health Organization. (2022). WHO Stroke Fact Sheet. Geneva: World Health Organization. Retrieved from https://www.who.int/news-room/fact-sheets/detail/stroke
12.Khatamov, N., & Rasulova, D. (2022). Clinical patterns and outcomes of stroke patients in Uzbekistan: A regional hospital-based study. Central Asian Journal of Medical Research, 9(3), 145–152
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

Germany
United States of America
Italy
United Kingdom
France
Canada
Uzbekistan
Japan
Republic of Korea
Australia
Spain
Switzerland
Sweden
Netherlands
China
India